"We gain from this agreement an additional pathway to discuss with physicians the importance of better specificity in diagnosing liver malignancies. These discussions have the potential to build on the safety and clinical efficacy advantages that Olympus' current EUS-guided technologies already bring to physicians and their patients," said Richard Reynolds, President, Medical Systems Group, Olympus Corporation of the Americas. "We are looking forward to good synergies that will provide more options for the diagnosis of focal liver lesions."ii
Those interested can visit the Endo-Hepatology station at the Olympus booth #4323 during the upcoming Digestive Disease Week (DDW) held in San Diego, May 21-24, 2022.
Ad Statistics
Times Displayed: 21280
Times Visited: 416 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About Olympus
Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people's lives healthier, safer and more fulfilling by helping to detect, prevent, and treat disease.
As a leading medical technology company, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients and their safety. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments for endoscopic and therapeutic applications.
SOURCE Olympus
Back to HCB News
